Gene Modified T Cell Therapies for Hematological Malignancies

被引：5
|
作者：
Abramowski-Mock, Ulrike [1 ]
Delhove, Juliette M. [1 ]
Qasim, Waseem [1 ]
机构：
[1] UCL, Mol & Cellular Immunol Unit, UCL Great Ormond St Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2017年 / 31卷 / 05期
基金：
“创新英国”项目;
关键词：
Gene therapy; Gene editing; Adoptive immunotherapy; T cell receptor; Chimeric antigen receptor; Lentiviral vectors; Leukemia; Lymphoma; CHIMERIC-ANTIGEN-RECEPTOR; ACUTE MYELOID-LEUKEMIA; ZINC-FINGER NUCLEASES; B-CELL; CANCER-IMMUNOTHERAPY; ADOPTIVE IMMUNOTHERAPY; IMMUNE CHECKPOINTS; MULTIPLE-MYELOMA; CLINICAL-TRIAL; LYMPHOCYTES;
D O I：
10.1016/j.hoc.2017.06.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This article focuses on clinical applications of T cells transduced to express recombinant T-cell receptor and chimeric antigen receptor constructs directed toward hematological malignancies, and considers newer strategies incorporating gene-editing technologies to address graft-versus-host disease and host-mediated rejection. Recent data from clinical trials are reviewed, and an overview is provided of current and emerging manufacturing processes; consideration is also given to new developments in the pipeline.
引用
收藏
页码：913 / +
页数：15
相关论文
共 50 条
  • [1] Cell therapies for hematological malignancies: don't forget non-gene-modified t cells!
    Grant, Melanie L.
    Bollard, Catherine M.
    BLOOD REVIEWS, 2018, 32 (03) : 203 - 224
  • [2] Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors
    Fujiwara, Hiroshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (02) : 123 - 131
  • [3] The application of CAR-T cell therapy in hematological malignancies: advantages and challenges
    Zhao, Zijun
    Chen, Yu
    Francisco, Ngiambudulu M.
    Zhang, Yuanqing
    Wu, Minhao
    ACTA PHARMACEUTICA SINICA B, 2018, 8 (04) : 539 - 551
  • [4] Chimeric antigen receptor modified T cell therapy for B cell malignancies
    Turtle, Cameron J.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (02) : 132 - 140
  • [5] Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors
    Hiroshi Fujiwara
    International Journal of Hematology, 2014, 99 : 123 - 131
  • [6] A guide to manufacturing CAR T cell therapies
    Vormittag, Philipp
    Gunn, Rebecca
    Ghorashian, Sara
    Veraitch, Farlan S.
    CURRENT OPINION IN BIOTECHNOLOGY, 2018, 53 : 164 - 181
  • [7] The Evolution of T-cell Therapies for Solid Malignancies
    Fousek, Kristen
    Ahmed, Nabil
    CLINICAL CANCER RESEARCH, 2015, 21 (15) : 3384 - 3392
  • [8] CAR T Cell Therapy for Hematological Malignancies
    Yang, Xin
    Wang, Gao-xiang
    Zhou, Jian-feng
    CURRENT MEDICAL SCIENCE, 2019, 39 (06) : 874 - 882
  • [9] Adoptive Immunotherapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors
    Fujiwara, Hiroshi
    PHARMACEUTICALS, 2014, 7 (12): : 1049 - 1068
  • [10] Immunotherapy with gene-modified T cells: limiting side effects provides new challenges
    Stauss, H. J.
    Morris, E. C.
    GENE THERAPY, 2013, 20 (11) : 1029 - 1032
12345